Umbilical Cord-Derived Mesenchymal Stem Cells are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications

Mesenchymal stem cells (MSCs) have become a promising tool in cellular therapy for restoring immune system haemostasis; however, the success of clinical trials has been impaired by the lack of standardized manufacturing processes. This study aims to determine the suitability of source tissues and cu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lenka Tesarova, Klara Jaresova, Pavel Simara, Irena Koutna
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-07-01
Series:International Journal of Molecular Sciences
Assuntos:
mesenchymal stem cells
umbilical cord
advanced therapy medicinal product
immunosuppression
Acceso en liña:https://www.mdpi.com/1422-0067/21/15/5366
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares